Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/113962| Title: | Guidelines for quality control of medical cannabis |
| Authors: | Mifsud, Julian Vella Szijj, Janis Azzopardi, Lilian M. |
| Keywords: | Cannabis -- Utilization Cannabis -- Therapeutic use -- Law and legislation Pain -- Treatment |
| Issue Date: | 2023 |
| Citation: | J. Mifsud, J. Vella Szijj, & L. M. Azzopardi (2023). Guidelines for quality control of medical cannabis. Poster session presented at the International Pharmaceutical Federation 81st World Congress of Pharmacy, Brisbane, Australia. |
| Abstract: | Medicinal cannabis is used for management of cancer and visceral pain, neuroinflammatory and neurodegenerative disorders, epilepsy, spasms and inflammatory bowel disease Quality Control ( of medicinal cannabis is required for patient safety. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/113962 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Guidelines_for_quality_control_of_medical_cannabis(2023).pdf | 225.66 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.